2026 data Public-data reference. official source

Nebulizer (Direct Patient Interface)

Open-data reference.

FDA MAUDE adverse event data · 1992–2026

What the Data Shows About Nebulizer (Direct Patient Interface)

The FDA MAUDE database aggregates 2,671 adverse-event reports for Nebulizer (Direct Patient Interface) spanning the period from 1992 through 2026. Of these, 42 are classified as death reports, 248 as injury reports, and 2,239 as malfunction reports under FDA adverse-event categorization rules. Report counts do not by themselves indicate a device is unsafe — widely used devices and longer market histories naturally generate larger raw counts, so proportional and comparative reads are more informative than totals alone.

The adverse-event profile breaks down across 5 distinct event types and 12 reported patient-outcome categories, giving a multi-dimensional view that goes beyond a single headline number. A total of 20 distinct product-problem codes appear in the reports, with Failure to Deliver topping the list at 379 reports. Reports are associated with 10 different manufacturers in the MAUDE record, reflecting both OEMs and repackagers of this device category.

Annual reporting volume is tracked across 35 years of MAUDE data, with the peak single-year volume reaching 256 reports — trend shape often reflects changes in device adoption, reporting rules, or FDA enforcement focus rather than underlying device behavior alone. Events are documented across 13 reported care-setting categories (hospital, home, ambulatory surgery center, etc.). All figures reflect the openFDA MAUDE snapshot last refreshed on . This page is informational and is not medical advice — discuss device-safety questions with your healthcare provider.

2,671
Total Reports
42
Death Reports
248
Injury Reports
2,239
Malfunctions

Event Types

Malfunction 2,239 (83.8%)
Injury 248 (9.3%)
Other 90 (3.4%)
52 (1.9%)
Death 42 (1.6%)

Patient Outcomes

2,149 (78.9%)
Other 285 (10.5%)
Required Intervention 84 (3.1%)
Hospitalization 80 (2.9%)
Death 43 (1.6%)
R 28 (1.0%)
Life Threatening 23 (0.8%)
O 9 (0.3%)
L 8 (0.3%)
Disability 6 (0.2%)
H 5 (0.2%)
S 5 (0.2%)

Top Product Problems

Failure to Deliver 379
Leak/Splash 135
Connection Problem 121
Break 75
Infusion or Flow Problem 72
Disconnection 62
Defective Device 46
Fitting Problem 45
No Flow 40
Device Operates Differently Than Expected 36
Adverse Event Without Identified Device or Use Problem 32
Therapeutic or Diagnostic Output Failure 31
Electrical /Electronic Property Problem 30
Fluid/Blood Leak 28
Use of Device Problem 28
Mechanical Problem 27
Insufficient Information 25
Detachment of Device or Device Component 21
Inaccurate Delivery 21
Improper Flow or Infusion 20

Yearly Trend

92
1992: 3
93
1993: 2
94
1994: 9
95
1995: 6
96
1996: 6
97
1997: 6
98
1998: 15
99
1999: 17
00
2000: 17
01
2001: 9
02
2002: 9
03
2003: 11
04
2004: 11
05
2005: 5
06
2006: 11
07
2007: 26
08
2008: 11
09
2009: 15
10
2010: 37
11
2011: 237
12
2012: 138
13
2013: 217
14
2014: 123
15
2015: 166
16
2016: 201
17
2017: 256
18
2018: 162
19
2019: 185
20
2020: 117
21
2021: 161
22
2022: 55
23
2023: 107
24
2024: 102
25
2025: 193
26
2026: 25

Related Entities for Nebulizer (Direct Patient Interface)

Event Locations

1,316 (49.3%)
I 1,020 (38.2%)
NO INFORMATION 148 (5.5%)
HOSPITAL 115 (4.3%)
HOME 40 (1.5%)
INVALID DATA 7 (0.3%)
UNKNOWN 7 (0.3%)
NURSING HOME 6 (0.2%)
OTHER 5 (0.2%)
OUTPATIENT TREATMENT FACILITY 3 (0.1%)
NOT APPLICABLE 2 (0.1%)
AMBULATORY SURGICAL FACILITY 1 (0.0%)
OUTPATIENT CLINIC/SURGERY 1 (0.0%)

Compare TELEFLEX MEDICAL vs PARI RESPIRATORY EQUIPMENT, INC. →

Data Source

FDA Manufacturer and User Facility Device Experience (MAUDE) database via the openFDA API. Reports are submitted by manufacturers, healthcare facilities, and patients. Report counts do not indicate a device is unsafe — higher-use devices naturally generate more reports.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the FDA MAUDE database. Consult a qualified professional before making decisions based on this data.